Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
2023 · Cancers · 576 citations
https://doi.org/10.3390/cancers15020485
S
Shahid Ahmed
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
252
Papers
5.1K
Citations
37
h-index
82
i10-index
Shahid Ahmed is an academic researcher from Saskatchewan Cancer Agency. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Gastric Cancer Management and Outcomes & Pancreatic and Hepatic Oncology Research. The author has an h-index of 37, co-authored 215 publications.
ORCID: 0000-0002-2099-698XPapers by this author
worksHER2-directed therapy: current treatment options for HER2-positive breast cancer
2015 · Breast Cancer · 180 citations
https://doi.org/10.1007/s12282-015-0587-x
Gastric biomarkers: a global review
2016 · World Journal of Surgical Oncology · 102 citations
https://doi.org/10.1186/s12957-016-0969-3
Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice
2013 · Breast Cancer Research and Treatment · 47 citations
https://doi.org/10.1007/s10549-013-2626-7
Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a population-based cohort study
2022 · Scientific Reports · 18 citations
https://doi.org/10.1038/s41598-022-05209-8
Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses
2013 · Cancer Gene Therapy · 16 citations
https://doi.org/10.1038/cgt.2013.60
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat